Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid

A multicenter study

Raina N. Fichorova, Nicola Richardson-Harman, Massimo Alfano, Laurent Belec, Cedric Carbonneil, Silvia Chen, Lisa Cosentino, Kelly Curtis, Charlene S. Dezzutti, Betty Donoval, Gustavo F. Doncel, Melissa Donaghay, Jean-Charles B. Grivel, Esmeralda Guzman, Madeleine Hayes, Betsy Herold, Sharon Hillier, Carol Lackman-Smith, Alan Landay, Leonid Margolis & 11 others Kenneth H. Mayer, Jenna Malia Pasicznyk, Melanie Pallansch-Cokonis, Guido Poli, Patricia Reichelderfer, Paula Roberts, Irma Rodriguez, Hela Saidi, Rosaria Rita Sassi, Robin Shattock, James E. Cummins

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

The increase of proinflammatory cytokines in vaginal secretions may serve as a surrogate marker of unwanted inflammatory reaction to microbicide products topically applied for the prevention of sexually transmitted diseases, including HIV-1. Interleukin (IL)-1β and IL-6 have been proposed as indicators of inflammation and increased risk of HIV-1 transmission; however, the lack of information regarding detection platforms optimal for vaginal fluids and interlaboratory variation limit their use for microbicide evaluation and other clinical applications. This study examines fluid matrix variants relevant to vaginal sampling techniques and proposes a model for interlaboratory comparisons across current cytokine detection technologies. IL-1β and IL-6 standards were measured by 12 laboratories in four countries, using 14 immunoassays and four detection platforms based on absorbance, chemiluminescence, electrochemilumines cence, and fluorescence. International reference preparations of cytokines with defined biological activity were spiked into (1) a defined medium simulating the composition of human vaginal fluid at pH 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for vaginal lavage sampling in clinical studies of cytokines, and (3) human blood serum. Assays were assessed for reproducibility, linearity, accuracy, and significantly detectable fold difference in cytokine level. Factors with significant impact on cytokine recovery were determined by Kruskal-Wallis analysis of variance with Dunn's multiple comparison test and multiple regression models. All assays showed acceptable intra-assay reproducibility; however, most were associated with significant interlaboratory variation. The smallest reliably detectable cytokine differences (P < 0.05) derived from pooled interlaboratory data varied from 1.5- to 26-fold depending on assay, cytokine, and matrix type. IL-6 but not IL-1β determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid matrix, with no significant effect of pH. The (electro)chemiluminescence-based assays were most discriminative and consistently detected <2-fold differences within each matrix type. The Luminex-based assays were less discriminative with lower reproducibility between laboratories. These results suggest the need for uniform vaginal sampling techniques and a better understanding of immunoassay platform differences and cross-validation before the biological significance of cytokine variations can be validated in clinical trials. This investigation provides the first standardized analytic approach for assessing differences in mucosal cytokine levels and may improve strategies for monitoring immune responses at the vaginal mucosal interface.

Original languageEnglish
Pages (from-to)4741-4751
Number of pages11
JournalAnalytical Chemistry
Volume80
Issue number12
DOIs
Publication statusPublished - 15 Jun 2008
Externally publishedYes

Fingerprint

Immunoassay
Multicenter Studies
Cytokines
Recovery
Fluids
Assays
Serum
Interleukin-1
Interleukin-6
Chemiluminescence
Sampling
Anti-Infective Agents
Luminescence
HIV-1
Vaginal Douching
Phosphates
Immunologic Monitoring
Sexually Transmitted Diseases
Analysis of variance (ANOVA)
Bioactivity

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Fichorova, R. N., Richardson-Harman, N., Alfano, M., Belec, L., Carbonneil, C., Chen, S., ... Cummins, J. E. (2008). Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study. Analytical Chemistry, 80(12), 4741-4751. https://doi.org/10.1021/ac702628q

Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid : A multicenter study. / Fichorova, Raina N.; Richardson-Harman, Nicola; Alfano, Massimo; Belec, Laurent; Carbonneil, Cedric; Chen, Silvia; Cosentino, Lisa; Curtis, Kelly; Dezzutti, Charlene S.; Donoval, Betty; Doncel, Gustavo F.; Donaghay, Melissa; Grivel, Jean-Charles B.; Guzman, Esmeralda; Hayes, Madeleine; Herold, Betsy; Hillier, Sharon; Lackman-Smith, Carol; Landay, Alan; Margolis, Leonid; Mayer, Kenneth H.; Pasicznyk, Jenna Malia; Pallansch-Cokonis, Melanie; Poli, Guido; Reichelderfer, Patricia; Roberts, Paula; Rodriguez, Irma; Saidi, Hela; Sassi, Rosaria Rita; Shattock, Robin; Cummins, James E.

In: Analytical Chemistry, Vol. 80, No. 12, 15.06.2008, p. 4741-4751.

Research output: Contribution to journalArticle

Fichorova, RN, Richardson-Harman, N, Alfano, M, Belec, L, Carbonneil, C, Chen, S, Cosentino, L, Curtis, K, Dezzutti, CS, Donoval, B, Doncel, GF, Donaghay, M, Grivel, J-CB, Guzman, E, Hayes, M, Herold, B, Hillier, S, Lackman-Smith, C, Landay, A, Margolis, L, Mayer, KH, Pasicznyk, JM, Pallansch-Cokonis, M, Poli, G, Reichelderfer, P, Roberts, P, Rodriguez, I, Saidi, H, Sassi, RR, Shattock, R & Cummins, JE 2008, 'Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study', Analytical Chemistry, vol. 80, no. 12, pp. 4741-4751. https://doi.org/10.1021/ac702628q
Fichorova, Raina N. ; Richardson-Harman, Nicola ; Alfano, Massimo ; Belec, Laurent ; Carbonneil, Cedric ; Chen, Silvia ; Cosentino, Lisa ; Curtis, Kelly ; Dezzutti, Charlene S. ; Donoval, Betty ; Doncel, Gustavo F. ; Donaghay, Melissa ; Grivel, Jean-Charles B. ; Guzman, Esmeralda ; Hayes, Madeleine ; Herold, Betsy ; Hillier, Sharon ; Lackman-Smith, Carol ; Landay, Alan ; Margolis, Leonid ; Mayer, Kenneth H. ; Pasicznyk, Jenna Malia ; Pallansch-Cokonis, Melanie ; Poli, Guido ; Reichelderfer, Patricia ; Roberts, Paula ; Rodriguez, Irma ; Saidi, Hela ; Sassi, Rosaria Rita ; Shattock, Robin ; Cummins, James E. / Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid : A multicenter study. In: Analytical Chemistry. 2008 ; Vol. 80, No. 12. pp. 4741-4751.
@article{a5273b036b804e13a90bcb069f9696a6,
title = "Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study",
abstract = "The increase of proinflammatory cytokines in vaginal secretions may serve as a surrogate marker of unwanted inflammatory reaction to microbicide products topically applied for the prevention of sexually transmitted diseases, including HIV-1. Interleukin (IL)-1β and IL-6 have been proposed as indicators of inflammation and increased risk of HIV-1 transmission; however, the lack of information regarding detection platforms optimal for vaginal fluids and interlaboratory variation limit their use for microbicide evaluation and other clinical applications. This study examines fluid matrix variants relevant to vaginal sampling techniques and proposes a model for interlaboratory comparisons across current cytokine detection technologies. IL-1β and IL-6 standards were measured by 12 laboratories in four countries, using 14 immunoassays and four detection platforms based on absorbance, chemiluminescence, electrochemilumines cence, and fluorescence. International reference preparations of cytokines with defined biological activity were spiked into (1) a defined medium simulating the composition of human vaginal fluid at pH 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for vaginal lavage sampling in clinical studies of cytokines, and (3) human blood serum. Assays were assessed for reproducibility, linearity, accuracy, and significantly detectable fold difference in cytokine level. Factors with significant impact on cytokine recovery were determined by Kruskal-Wallis analysis of variance with Dunn's multiple comparison test and multiple regression models. All assays showed acceptable intra-assay reproducibility; however, most were associated with significant interlaboratory variation. The smallest reliably detectable cytokine differences (P < 0.05) derived from pooled interlaboratory data varied from 1.5- to 26-fold depending on assay, cytokine, and matrix type. IL-6 but not IL-1β determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid matrix, with no significant effect of pH. The (electro)chemiluminescence-based assays were most discriminative and consistently detected <2-fold differences within each matrix type. The Luminex-based assays were less discriminative with lower reproducibility between laboratories. These results suggest the need for uniform vaginal sampling techniques and a better understanding of immunoassay platform differences and cross-validation before the biological significance of cytokine variations can be validated in clinical trials. This investigation provides the first standardized analytic approach for assessing differences in mucosal cytokine levels and may improve strategies for monitoring immune responses at the vaginal mucosal interface.",
author = "Fichorova, {Raina N.} and Nicola Richardson-Harman and Massimo Alfano and Laurent Belec and Cedric Carbonneil and Silvia Chen and Lisa Cosentino and Kelly Curtis and Dezzutti, {Charlene S.} and Betty Donoval and Doncel, {Gustavo F.} and Melissa Donaghay and Grivel, {Jean-Charles B.} and Esmeralda Guzman and Madeleine Hayes and Betsy Herold and Sharon Hillier and Carol Lackman-Smith and Alan Landay and Leonid Margolis and Mayer, {Kenneth H.} and Pasicznyk, {Jenna Malia} and Melanie Pallansch-Cokonis and Guido Poli and Patricia Reichelderfer and Paula Roberts and Irma Rodriguez and Hela Saidi and Sassi, {Rosaria Rita} and Robin Shattock and Cummins, {James E.}",
year = "2008",
month = "6",
day = "15",
doi = "10.1021/ac702628q",
language = "English",
volume = "80",
pages = "4741--4751",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid

T2 - A multicenter study

AU - Fichorova, Raina N.

AU - Richardson-Harman, Nicola

AU - Alfano, Massimo

AU - Belec, Laurent

AU - Carbonneil, Cedric

AU - Chen, Silvia

AU - Cosentino, Lisa

AU - Curtis, Kelly

AU - Dezzutti, Charlene S.

AU - Donoval, Betty

AU - Doncel, Gustavo F.

AU - Donaghay, Melissa

AU - Grivel, Jean-Charles B.

AU - Guzman, Esmeralda

AU - Hayes, Madeleine

AU - Herold, Betsy

AU - Hillier, Sharon

AU - Lackman-Smith, Carol

AU - Landay, Alan

AU - Margolis, Leonid

AU - Mayer, Kenneth H.

AU - Pasicznyk, Jenna Malia

AU - Pallansch-Cokonis, Melanie

AU - Poli, Guido

AU - Reichelderfer, Patricia

AU - Roberts, Paula

AU - Rodriguez, Irma

AU - Saidi, Hela

AU - Sassi, Rosaria Rita

AU - Shattock, Robin

AU - Cummins, James E.

PY - 2008/6/15

Y1 - 2008/6/15

N2 - The increase of proinflammatory cytokines in vaginal secretions may serve as a surrogate marker of unwanted inflammatory reaction to microbicide products topically applied for the prevention of sexually transmitted diseases, including HIV-1. Interleukin (IL)-1β and IL-6 have been proposed as indicators of inflammation and increased risk of HIV-1 transmission; however, the lack of information regarding detection platforms optimal for vaginal fluids and interlaboratory variation limit their use for microbicide evaluation and other clinical applications. This study examines fluid matrix variants relevant to vaginal sampling techniques and proposes a model for interlaboratory comparisons across current cytokine detection technologies. IL-1β and IL-6 standards were measured by 12 laboratories in four countries, using 14 immunoassays and four detection platforms based on absorbance, chemiluminescence, electrochemilumines cence, and fluorescence. International reference preparations of cytokines with defined biological activity were spiked into (1) a defined medium simulating the composition of human vaginal fluid at pH 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for vaginal lavage sampling in clinical studies of cytokines, and (3) human blood serum. Assays were assessed for reproducibility, linearity, accuracy, and significantly detectable fold difference in cytokine level. Factors with significant impact on cytokine recovery were determined by Kruskal-Wallis analysis of variance with Dunn's multiple comparison test and multiple regression models. All assays showed acceptable intra-assay reproducibility; however, most were associated with significant interlaboratory variation. The smallest reliably detectable cytokine differences (P < 0.05) derived from pooled interlaboratory data varied from 1.5- to 26-fold depending on assay, cytokine, and matrix type. IL-6 but not IL-1β determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid matrix, with no significant effect of pH. The (electro)chemiluminescence-based assays were most discriminative and consistently detected <2-fold differences within each matrix type. The Luminex-based assays were less discriminative with lower reproducibility between laboratories. These results suggest the need for uniform vaginal sampling techniques and a better understanding of immunoassay platform differences and cross-validation before the biological significance of cytokine variations can be validated in clinical trials. This investigation provides the first standardized analytic approach for assessing differences in mucosal cytokine levels and may improve strategies for monitoring immune responses at the vaginal mucosal interface.

AB - The increase of proinflammatory cytokines in vaginal secretions may serve as a surrogate marker of unwanted inflammatory reaction to microbicide products topically applied for the prevention of sexually transmitted diseases, including HIV-1. Interleukin (IL)-1β and IL-6 have been proposed as indicators of inflammation and increased risk of HIV-1 transmission; however, the lack of information regarding detection platforms optimal for vaginal fluids and interlaboratory variation limit their use for microbicide evaluation and other clinical applications. This study examines fluid matrix variants relevant to vaginal sampling techniques and proposes a model for interlaboratory comparisons across current cytokine detection technologies. IL-1β and IL-6 standards were measured by 12 laboratories in four countries, using 14 immunoassays and four detection platforms based on absorbance, chemiluminescence, electrochemilumines cence, and fluorescence. International reference preparations of cytokines with defined biological activity were spiked into (1) a defined medium simulating the composition of human vaginal fluid at pH 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for vaginal lavage sampling in clinical studies of cytokines, and (3) human blood serum. Assays were assessed for reproducibility, linearity, accuracy, and significantly detectable fold difference in cytokine level. Factors with significant impact on cytokine recovery were determined by Kruskal-Wallis analysis of variance with Dunn's multiple comparison test and multiple regression models. All assays showed acceptable intra-assay reproducibility; however, most were associated with significant interlaboratory variation. The smallest reliably detectable cytokine differences (P < 0.05) derived from pooled interlaboratory data varied from 1.5- to 26-fold depending on assay, cytokine, and matrix type. IL-6 but not IL-1β determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid matrix, with no significant effect of pH. The (electro)chemiluminescence-based assays were most discriminative and consistently detected <2-fold differences within each matrix type. The Luminex-based assays were less discriminative with lower reproducibility between laboratories. These results suggest the need for uniform vaginal sampling techniques and a better understanding of immunoassay platform differences and cross-validation before the biological significance of cytokine variations can be validated in clinical trials. This investigation provides the first standardized analytic approach for assessing differences in mucosal cytokine levels and may improve strategies for monitoring immune responses at the vaginal mucosal interface.

UR - http://www.scopus.com/inward/record.url?scp=45249115925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249115925&partnerID=8YFLogxK

U2 - 10.1021/ac702628q

DO - 10.1021/ac702628q

M3 - Article

VL - 80

SP - 4741

EP - 4751

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 12

ER -